$9.07
-0.97-9.66%
In chiusura: -
$9.00
-0.07-0.75%
After hour: Oct 10, 7:01 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Emergent BioSolutions segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 29
Stima EPS
$0.060
Stima dei ricavi trimestrali
$201.40M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$812.50M
Analizza lo storico degli utili di Emergent BioSolutions utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
EBS | Emergent BioSolutions | $1.37 | $0.06 | — | — | $293.80M | $201.40M | — | — | 10/29/2025 | |
EBS | Emergent BioSolutions | -$2.32 | -$0.40 | $0.16 | 140.00% | $254.70M | $154.60M | $140.90M | -8.86% | 08/06/2025 | |
EBS | Emergent BioSolutions | $0.59 | $0.44 | $0.71 | 61.36% | $300.40M | — | $222.20M | — | 05/07/2025 | |
EBS | Emergent BioSolutions | -$0.77 | -$0.50 | $0.05 | 110.00% | $276.60M | $254.67M | $194.70M | -23.55% | 03/03/2025 | |
EBS | Emergent BioSolutions | -$1.09 | $0.14 | $1.37 | 878.57% | $270.50M | $297.50M | $293.80M | -1.24% | 11/06/2024 | |
EBS | Emergent BioSolutions | -$1.06 | -$0.94 | -$2.32 | -146.81% | $337.90M | $190.00M | $254.70M | 34.05% | 08/06/2024 | |
EBS | Emergent BioSolutions | -$3.26 | -$0.83 | $0.59 | 171.08% | $164.30M | $224.50M | $300.40M | 33.81% | 05/01/2024 | |
EBS | Emergent BioSolutions | -$0.31 | -$0.19 | -$0.77 | -305.26% | $330.70M | $293.53M | $276.60M | -5.77% | 03/06/2024 | |
EBS | Emergent BioSolutions | -$1.27 | -$0.22 | -$0.87 | -295.45% | $240.00M | $237.43M | $270.50M | 13.93% | 11/08/2023 | |
EBS | Emergent BioSolutions | -$0.86 | -$0.47 | -$1.06 | -125.53% | $242.70M | $217.03M | $337.90M | 55.69% | 08/08/2023 | |
EBS | Emergent BioSolutions | $0.18 | -$1.24 | -$3.17 | -155.65% | $307.50M | $143.28M | $165.10M | 15.23% | 05/09/2023 | |
EBS | Emergent BioSolutions | $4.50 | $0.04 | -$0.31 | -875.00% | $723.20M | $296.62M | $330.70M | 11.49% | 02/27/2023 | |
EBS | Emergent BioSolutions | -$0.36 | -$0.06 | -$1.27 | -2016.67% | $329.00M | $268.30M | $240.00M | -10.55% | 11/08/2022 | |
EBS | Emergent BioSolutions | $0.33 | $0.37 | -$0.86 | -332.43% | $397.50M | $270.94M | $242.70M | -10.42% | 08/01/2022 | |
EBS | Emergent BioSolutions | $1.53 | $0.12 | $0.18 | 50.00% | $343.00M | $283.00M | $307.50M | 8.66% | 04/28/2022 | |
EBS | Emergent BioSolutions | $3.67 | $4.27 | $4.50 | 5.39% | $583.00M | $691.36M | $723.20M | 4.61% | 02/24/2022 | |
EBS | Emergent BioSolutions | $2.19 | $2.35 | -$0.36 | -115.32% | $385.20M | $486.84M | $329.00M | -32.42% | 11/04/2021 | |
EBS | Emergent BioSolutions | $1.98 | $1.54 | $0.33 | -78.57% | $394.70M | $398.93M | $397.50M | -0.36% | 07/29/2021 | |
EBS | Emergent BioSolutions | $0.01 | $1.12 | $1.53 | 36.61% | $192.50M | $358.47M | $343.00M | -4.32% | 04/29/2021 | |
EBS | Emergent BioSolutions | $1.57 | $3.19 | $3.67 | 15.05% | $360.40M | $563.60M | $583.00M | 3.44% | 02/18/2021 | |
EBS | Emergent BioSolutions | $1.21 | $2.12 | $2.19 | 3.30% | $311.80M | $437.93M | $385.20M | -12.04% | 11/05/2020 |
Emergent BioSolutions (EBS) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.16 | $-0.40 | 140.0 % |
| Q1 | 2025-05-07 | $0.71 | $0.44 | 61.4 % |
| Q4 | 2025-03-03 | $0.05 | $-0.50 | 110.0 % |
| Q3 | 2024-11-06 | $1.37 | $0.14 | 878.6 % |
Emergent BioSolutions (EBS) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $140.90M | $154.60M | -8.86 % |
| Q4 | 2025-03-03 | $194.70M | $254.67M | -23.5 % |
| Q3 | 2024-11-06 | $293.80M | $297.50M | -1.24 % |
| Q2 | 2024-08-06 | $254.70M | $190.00M | 34.1 % |
FAQ
Quando Emergent BioSolutions (NYSE:EBS) riporterà gli utili?
Si prevede che Emergent BioSolutions (EBS) fornisca risultati il ottobre 29, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Emergent BioSolutions (NYSE:EBS)?
L'EPS effettivo era $0.16, che superato la stima di $-0.40.
Quali sono state le entrate di Emergent BioSolutions (NYSE:EBS)?
Le entrate effettive sono state $140.9M, che mancato la stima di $154.6M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.